Access your copy by filling out a few details.
Please provide a few details to read our special report "Under the Microscope". Based on meeting notes from 2020 company engagements, this report explores the unique governance and compensations challenges faced by companies in the Biopharma industry.
This report is part of a growing library of ESG-focused literature that illuminates the topics at the top of the agenda for investors and public companies.
A little about us.
Glass Lewis is a trusted ally of the world's leading investors who use our solutions to drive value across all their governance activities. Our clients, including the majority of the world’s largest pension plans, mutual funds, and asset managers, collectively manage more than $40 trillion in assets.
Our teams are located in the United States, Europe, and Asia-Pacific giving us global reach with a local perspective. We cover 30,000+ meetings each year, across 100+ global markets.